The effects of endocrine disruptors on human health and reproduction raise a lot of concern and emotions among the general public. On what basis should they be assessed to be best regulated? According to the potential hazard they represent or according to the risk they actually involve? The debate is raging among political and scientific spheres. Gisela Degen came to the second Cosmetics Europe International Conference held last June 16-17, 2015, in Brussels to explain where the SCCS stands.